Episode 2: Alan Lotvin, MD, CEO and Co-Founder of Sequel Med Tech episode artwork

EPISODE · Jan 27, 2025 · 52 MIN

Episode 2: Alan Lotvin, MD, CEO and Co-Founder of Sequel Med Tech

from Digital Health Heavyweights · host Norm Volsky

Welcome back to the Second Season of The Digital Health Heavyweights Podcast for Episode 2! In today’s sit down, Norm Volsky interviews Alan Lotvin, CEO and co-founder of Sequel Med Tech. Alan shares his journey from being a practicing cardiologist to leading various healthcare organizations, including CVS Caremark. He discusses the challenges and opportunities in the diabetes care space, particularly focusing on innovative drug delivery systems. Alan emphasizes the importance of collaboration in healthcare and the evolving role of pharmacy benefit managers (PBMs) in making healthcare more affordable. He also shares insights into his personal health practices and the future direction of Sequel Med Tech. Takeaways 👨‍⚕️ Alan Lotvin transitioned from cardiology to healthcare leadership. 🧑‍💼 The importance of recruiting top talent in healthcare organizations. 💊 PBMs play a crucial role in managing drug costs and healthcare affordability. 💡 Sequel Med Tech aims to simplify diabetes care through innovative technology. 🤝 Collaboration is key in healthcare decision-making processes. 📈 The diabetes technology market is experiencing significant growth. ⏱️ Sequel's device offers real-time monitoring and alerts for insulin delivery. 🧠 Mental health is a critical aspect of managing chronic diseases like diabetes. 🏋️‍♀️🍏 Exercise and nutrition are vital for maintaining health and wellness. 🔜 Sequel Med Tech plans to expand its offerings to include type 2 diabetes solutions. Chapters 00:00 Introduction to Alan Lotvin and His Journey 03:05 Transition from Medicine to Business Leadership 05:40 Experience at CVS Caremark and Key Learnings 11:19 The Role of PBMs in Healthcare 17:43 Future of Pharmacy and Drug Pricing 23:23 Starting Sequel MedTech and Innovations in Diabetes Management 27:57 The Evolution of Diabetes Technology 29:56 Sequel’s Innovative Approach to Diabetes Care 36:30 The Impact of Diabetes on Mental Health 39:21 Future Directions for Sequel MedTech 43:11 Navigating the Changing Landscape of Diabetes Treatment 46:17 Expanding Beyond Diabetes: Future Opportunities 48:28 Personal Health Practices and Wellness Insights 53:32 Outro Follow, connect and subscribe:LinkedIn: https://www.linkedin.com/company/digital-health-heavyweights-podcastYoutube: https://youtube.com/@DigitalHealthHeavyweightsInstagram: https://www.instagram.com/digitalhealthheavyweights/TikTok: https://www.tiktok.com/@heavyweightspodcast

Episode metadata supplied by the publisher feed · Published Jan 27, 2025

Embed this episode

Welcome back to the Second Season of The Digital Health Heavyweights Podcast for Episode 2! In today’s sit down, Norm Volsky interviews Alan Lotvin, CEO and co-founder of Sequel Med Tech. Alan shares his journey from being a practicing cardiologist to leading various healthcare organizations, including CVS Caremark. He discusses the challenges and opportunities in the diabetes care space, particularly focusing on innovative drug delivery systems. Alan emphasizes the importance of collaboratio...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Episode 2: Alan Lotvin, MD, CEO and Co-Founder of Sequel Med Tech

0:00 52:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Digital Health Heavyweights?

This episode is 52 minutes long.

When was this Digital Health Heavyweights episode published?

This episode was published on January 27, 2025.

Can I download this Digital Health Heavyweights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!